The effect of ivermectin alone and in combination with cobicistat or elacridar in experimental Schistosoma mansoni infection in mice
Abstract Schistosoma mansoni is less susceptible to the antiparasitic drug ivermectin than other helminths. By inhibiting the P-glycoprotein or cytochrome P450 3A in mice host or parasites in a murine model, we aimed at increasing the sensitivity of S. mansoni to the drug and thus preventing infecti...
Guardado en:
Autores principales: | Belén Vicente, Julio López-Abán, Juliane Chaccour, Juan Hernández-Goenaga, Patricia Nicolas, Pedro Fernández-Soto, Antonio Muro, Carlos Chaccour |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/009dfc25093b418f859d617fa63c7155 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
por: Crutchley RD, et al.
Publicado: (2016) -
Ultraviolet disinfection of Schistosoma mansoni cercariae in water.
por: Lucinda Hazell, et al.
Publicado: (2021) -
The Activity of Plant Crude Extracts against Schistosoma mansoni
por: Hirut Basha, et al.
Publicado: (2021) -
Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
por: Dkhi,Mohamed A
Publicado: (2014) -
Daily rhythms in gene expression of the human parasite Schistosoma mansoni
por: Kate A. Rawlinson, et al.
Publicado: (2021)